A5014968374- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Peripheral Artery Disease Management
- Cardiac, Anesthesia and Surgical Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrest and Resuscitation
- Aortic Disease and Treatment Approaches
- Cerebrovascular and Carotid Artery Diseases
- Cardiac pacing and defibrillation studies
- Mechanical Circulatory Support Devices
- Atrial Fibrillation Management and Outcomes
- Cardiac Health and Mental Health
- Cardiac Structural Anomalies and Repair
- Acute Ischemic Stroke Management
- Blood Pressure and Hypertension Studies
- Health Systems, Economic Evaluations, Quality of Life
- Lipoproteins and Cardiovascular Health
- Vascular Procedures and Complications
- Healthcare Policy and Management
The University of Texas Southwestern Medical Center
2016-2025
Southwestern Medical Center
2015-2025
VA North Texas Health Care System
2012-2025
Dartmouth–Hitchcock Medical Center
2023
Vanderbilt University Medical Center
2021-2023
Duke University
2022
Clinical Research Institute
2016-2022
Faculty of 1000 (United States)
2019
Wroclaw University of Applied Informatics "Horizon"
2019
Cleveland Clinic
2008-2018
The objective of this study was to identify the determinants 30-day postoperative mortality and long-term survival after major surgery as exemplified by 8 common operations.
AIM: The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease” provides an update to and consolidates new evidence since “2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Diagnosis Stable Ischemic Heart corresponding “2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update Disease.” METHODS: A comprehensive literature search was conducted from September 2021 May 2022. Clinical studies, systematic reviews meta-analyses, other on human participants were identified...
During the introduction of transcatheter aortic-valve replacement (TAVR) in United States, requirements regarding procedural volume were mandated by Centers for Medicare and Medicaid Services as a condition reimbursement. A better understanding relationship between hospital TAVR procedures patient outcomes could inform policy decisions.
AimsDue to a high burden of systemic cardiovascular events, current guidelines recommend the use statins in all patients with peripheral artery disease (PAD). We sought study impact statin on limb prognosis symptomatic PAD enrolled international REACH registry.
The effect of resistant hypertension on outcomes in patients with atherothrombotic disease is currently unknown. Accordingly, we sought to determine the prevalence and stable hypertensive outpatients subclinical or established atherothombotic enrolled international Reduction Atherothrombosis for Continued Health (REACH) registry. Resistant was defined as a blood pressure ≥140/90 mmHg at baseline (≥130/80 if diabetes/renal insufficiency) use ≥3 antihypertensive medications, including...